ArticleHealthcare (Basel, Switzerland)2022

The Cost-Effectiveness Analysis of Gamiguibi-Tang versus Hwangryunhaedok-Tang for Patients with Insomnia Disorder Based on a Randomized Controlled Trial.

Ji-Eun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.